Hims & Hers Health, Inc. (NYSE:HIMS) Stock Holdings Increased by New York State Teachers Retirement System

New York State Teachers Retirement System raised its position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 95.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 194,795 shares of the company's stock after purchasing an additional 94,983 shares during the quarter. New York State Teachers Retirement System owned 0.09% of Hims & Hers Health worth $5,756,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Raymond James Financial Inc. purchased a new position in shares of Hims & Hers Health in the 4th quarter worth about $18,048,000. O Shaughnessy Asset Management LLC purchased a new position in shares of Hims & Hers Health in the 4th quarter worth about $208,000. Commonwealth Equity Services LLC raised its holdings in shares of Hims & Hers Health by 111.6% in the 4th quarter. Commonwealth Equity Services LLC now owns 58,894 shares of the company's stock worth $1,424,000 after purchasing an additional 31,062 shares during the period. PNC Financial Services Group Inc. raised its holdings in shares of Hims & Hers Health by 51.9% during the 4th quarter. PNC Financial Services Group Inc. now owns 17,225 shares of the company's stock valued at $417,000 after buying an additional 5,885 shares during the period. Finally, Amundi raised its holdings in shares of Hims & Hers Health by 49.1% during the 4th quarter. Amundi now owns 12,741 shares of the company's stock valued at $328,000 after buying an additional 4,197 shares during the period. 63.52% of the stock is currently owned by hedge funds and other institutional investors.

Hims & Hers Health Price Performance

NYSE:HIMS traded up $0.46 during midday trading on Friday, reaching $47.92. 17,394,334 shares of the company traded hands, compared to its average volume of 23,468,991. Hims & Hers Health, Inc. has a twelve month low of $13.47 and a twelve month high of $72.98. The firm has a market capitalization of $10.72 billion, a price-to-earnings ratio of 69.44, a price-to-earnings-growth ratio of 1.76 and a beta of 2.02. The company has a fifty day moving average price of $52.23 and a 200 day moving average price of $40.28.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.08. Hims & Hers Health had a return on equity of 22.75% and a net margin of 9.24%. The business had revenue of $586.01 million during the quarter, compared to analyst estimates of $535.21 million. During the same quarter in the previous year, the firm posted $0.05 EPS. The business's revenue for the quarter was up 110.7% compared to the same quarter last year. On average, equities research analysts forecast that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on HIMS. Needham & Company LLC reiterated a "hold" rating on shares of Hims & Hers Health in a report on Monday, June 23rd. Wall Street Zen upgraded Hims & Hers Health from a "hold" rating to a "buy" rating in a report on Sunday, June 15th. UBS Group set a $30.00 target price on Hims & Hers Health in a report on Monday, June 23rd. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Hims & Hers Health in a report on Wednesday, May 7th. Finally, Piper Sandler restated a "neutral" rating and set a $39.00 price objective (up previously from $35.00) on shares of Hims & Hers Health in a research note on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Hims & Hers Health currently has an average rating of "Hold" and a consensus price target of $39.58.

Insider Activity at Hims & Hers Health

In other Hims & Hers Health news, COO Melissa Baird sold 33,337 shares of Hims & Hers Health stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $27.32, for a total transaction of $910,766.84. Following the sale, the chief operating officer owned 805,083 shares of the company's stock, valued at $21,994,867.56. The trade was a 3.98% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Andrew Dudum sold 128,127 shares of Hims & Hers Health stock in a transaction on Friday, May 16th. The shares were sold at an average price of $58.40, for a total value of $7,482,616.80. Following the sale, the chief executive officer directly owned 89,311 shares in the company, valued at $5,215,762.40. The trade was a 58.93% decrease in their position. The disclosure for this sale can be found here. Insiders sold 692,006 shares of company stock worth $34,857,872 in the last 90 days. 13.71% of the stock is currently owned by company insiders.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.